Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bioatla, Inc. (BCAB)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 46,110,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   BioAtla is a biopharmaceutical company engaged in developing specific and selective antibody-based therapeutics for the treatment of various cancers. Co.'s lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. Co. also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 81,495 83,495 252,735
Total Buy Value $0 $172,540 $177,620 $814,041
Total People Bought 0 4 4 4
Total Buy Transactions 0 4 5 15
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 207
  Page 4 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mcbrinn Sylvia Director   –       •      –    2022-12-19 4 B $8.33 $30,813 D/D 3,700 9,125 2.39     -
   Vasquez Christian See Remarks   •       –      –    2022-11-30 4 D $11.01 $2,136 D/D (194) 83,361     -
   Smith Scott Andrew President   •       •      –    2022-11-30 4 D $11.01 $19,719 D/D (1,791) 322,671     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-11-30 4 D $11.01 $10,680 D/D (970) 132,744     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-11-30 4 D $11.01 $6,111 D/D (555) 94,508     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-11-30 4 D $11.01 $51,384 D/D (4,667) 1,382,659     -
   Mcbrinn Sylvia Director   –       •      –    2022-11-22 4 B $8.27 $16,540 D/D 2,000 5,425 2.39     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-10-31 4 D $6.89 $3,817 D/D (554) 85,063     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-10-31 4 D $6.89 $6,683 D/D (970) 123,714     -
   Smith Scott Andrew President   •       •      –    2022-10-31 4 D $6.89 $12,340 D/D (1,791) 324,462     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-10-31 4 D $6.89 $23,798 D/D (3,454) 1,387,326     -
   Vasquez Christian See Remarks   •       –      –    2022-10-31 4 D $6.89 $1,337 D/D (194) 73,555     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-09-30 4 D $7.70 $4,274 D/D (555) 85,617     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-09-30 4 D $7.70 $7,469 D/D (970) 124,684     -
   Vasquez Christian See Remarks   •       –      –    2022-09-30 4 D $7.70 $1,494 D/D (194) 73,749     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-09-30 4 D $7.70 $22,238 D/D (2,888) 1,390,780     -
   Smith Scott Andrew President   •       •      –    2022-09-30 4 D $7.70 $13,791 D/D (1,791) 326,253     -
   Mcbrinn Sylvia Director   –       •      –    2022-09-13 4 B $8.20 $8,200 D/D 1,000 3,000 2.39     -
   Mcbrinn Sylvia Director   –       •      –    2022-09-12 4 B $8.85 $17,700 D/D 2,000 2,000 2.39     -
   Sievers Eric Chief Medical Officer   •       –      –    2022-08-31 4 D $8.71 $4,834 D/D (555) 86,172     -
   Waldron Richard A Chief Financial Officer   •       –      –    2022-08-31 4 D $8.71 $8,449 D/D (970) 125,654     -
   Smith Scott Andrew President   •       •      –    2022-08-31 4 D $8.71 $15,600 D/D (1,791) 328,044     -
   Vasquez Christian See Remarks   •       –      –    2022-08-31 4 D $8.71 $1,690 D/D (194) 73,943     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-08-31 4 D $8.71 $25,154 D/D (2,888) 1,393,668     -
   Short Jay M Phd Chief Executive Officer   •       •       •   2022-08-12 4 B $7.84 $206,600 D/D 26,350 1,396,556 3.23     -
  207 Records found
  1  2  3  4  5  6  7  8  9   
  Page 4 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us